Terms: = Kidney tumors AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28 AND Treatment
7 results:
1. Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid tumors.
Jha S; Welch J; Tora R; Lack J; Warner A; Del Rivero J; Sadowski SM; Nilubol N; Schmidt LS; Linehan WM; Weinstein LS; Simonds WF; Agarwal SK
J Clin Endocrinol Metab; 2023 Sep; 108(10):2686-2698. PubMed ID: 36935552
[TBL] [Abstract] [Full Text] [Related]
2. A two-generation hyperparathyroidism-jaw tumor (hpt-jt) syndrome family: clinical presentations, pathological characteristics and genetic analysis: a case report.
Yang D; Zheng J; Tang F; He Q; Huang H; Zhou P
Diagn Pathol; 2022 Sep; 17(1):71. PubMed ID: 36153594
[TBL] [Abstract] [Full Text] [Related]
3. Familial kidney Cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
[TBL] [Abstract] [Full Text] [Related]
4. Familial and Hereditary Forms of Primary Hyperparathyroidism.
Cetani F; Saponaro F; Borsari S; Marcocci C
Front Horm Res; 2019; 51():40-51. PubMed ID: 30641519
[TBL] [Abstract] [Full Text] [Related]
5. Parathyroid carcinoma.
Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
[TBL] [Abstract] [Full Text] [Related]
6. Hyperparathyroidism-jaw tumor syndrome.
Kutcher MR; Rigby MH; Bullock M; Trites J; Taylor SM; Hart RD
Head Neck; 2013 Jun; 35(6):E175-7. PubMed ID: 22302605
[TBL] [Abstract] [Full Text] [Related]
7. Hereditary renal cancer syndromes: an update of a systematic review.
Verine J; Pluvinage A; Bousquet G; Lehmann-Che J; de Bazelaire C; Soufir N; Mongiat-Artus P
Eur Urol; 2010 Nov; 58(5):701-10. PubMed ID: 20817385
[TBL] [Abstract] [Full Text] [Related]
